STOCKHOLM August 30, 2019 – Today Coala Life announces entry into the Dutch market in partnership with Luscii. The Netherlands, with healthcare expenditures approaching $100 Bn, is a major and influential hub in the European medical device industry frequently ranked in the top 5 global medical device markets.
The Swedish medtech company Coala Life, pioneer in digital cardiac diagnosis and user-centered medical innovations, has partnered with Luscii, a leader in remote healthcare and telemonitoring. The two companies will jointly make the Coala Heart Monitor available in the Netherlands through Luscii’s platform. Luscii has previously achieved significant success in supplying patient-centered solutions and their EMR-integrated digital health platform is already in use in nearly 50% of the hospitals in the Netherlands.
- We are very pleased to join Luscii on their exciting journey to make healthcare more efficient. Their digital platform is world class and Coala could not have hoped for a better partner to enter the Netherlands with, says Dan Pitulia, CEO Coala Life AB.
- Cardiologists ask us for best in class ways to support their cardiac patients, such as the growing group with atrial fibrillation. We are thrilled to work with Coala to bring their state of the art innovations to doctors, nurses and their patients on the Luscii platform, comments Dr. Daan Dohmen, CEO Luscii.
The Coala Heart Monitor will initially be available to selected Luscii customers before a full launch. The partnership includes the option to jointly introduce the Coala Heart Monitor in the United Kingdom at a later stage.